• H. Lundbeck A/S, of Valby, Denmark, said the FDA approved Sabril (vigabatrin) as add-on therapy for the treatment of refractory complex partial seizures in children 10 years and older who have inadequately responded to several other treatments and if the possible benefit outweighs the risks of vision loss.